abiraterone News
Most Popular abiraterone Story
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Medivation CEO David Hung is a persuasive individual. He has negotiated some of the most lucrative drug development collaborations in biotechnology. Pfizer's $225 million upfront for Dimebon remains Read more...
Latest Headlines
- April 28, 2011
- October 11, 2010
- September 10, 2010
- February 17, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
